Skip to main content
OpenTrials

Clinical trial condition

Leukemia

Explore clinical trials studying Leukemia. Study availability and eligibility vary by location and protocol.

4,429 public trials 1,038 recruiting studies
Refine in advanced search Browse all conditions

Leukemia trial results

Completed

A Study of Pevonedistat and Venetoclax Combined With Azacitidine to Treat Acute Myeloid Leukemia (AML) in Adults Unable to Receive Intensive Chemotherapy

NCT04266795

Conditions
Acute Myeloid Leukemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • UC Irvine Medical Center Orange, California, United States
  • University of Miami Miller School of Medicine Miami, Florida, United States
View all 57 locations
View Trial Details
Completed

A Study in Adults With Untreated Acute Lymphoblastic Leukemia

NCT00136435

Conditions
Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • University Of Columbia Medical Center New York, United States
  • Manitoba Blood & Marrow Transplant Program CancerCare Manitoba Winnipeg, Manitoba, Canada
View Trial Details
Completed

BRAF Inhibitor, Vemurafenib, in Patients With Relapsed or Refractory Hairy Cell Leukemia

NCT01711632

Conditions
Hairy Cell Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
Locations
  • Scripps Clinic La Jolla, California, United States
  • Northwestern University Evanston, Illinois, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details
Completed

Asciminib in Monotherapy for Chronic Myeloid Leukemia in Chronic Phase (CML-CP) With and Without T315I Mutation

NCT04666259

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myelogenous Leukemia - Chronic Phase, +12 more
Locations
  • Alaska Oncology and Hematology Anchorage, Alaska, United States
  • Arizona Oncology Associates Phoenix, Arizona, United States
  • Cancer Treatment Centers of America Phoenix, Arizona, United States
  • Pacific Shores Medical Group Long Beach, California, United States
View all 26 locations
View Trial Details
Completed

Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax in Combination With Intravenous (IV) Obinutuzumab or Oral Ibrutinib in Adult Participants With Untreated Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

NCT05105841

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia (CLL), Disease Attributes, +15 more
Locations
  • Duplicate_NHO Nagoya Medical Center /ID# 233523 Nagoya, Aichi-ken, Japan
  • Aichi Cancer Center Hospital /ID# 238797 Nagoya, Aichi-ken, Japan
  • Duplicate_Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital /ID# 233524 Nagoya, Aichi-ken, Japan
  • Duplicate_Chiba Cancer Center /ID# 238839 Chiba, Japan
View all 20 locations
View Trial Details
Completed

IDH2 Inhibition Using Enasidenib as Maintenance Therapy for IDH2-mutant Myeloid Neoplasms Following Allogeneic Stem Cell Transplantation

NCT03515512

Conditions
Acute Myeloid Leukemia, Bone Marrow Diseases, Chronic Disease, +13 more
Locations
  • Johns Hopkins Cancer Center Baltimore, Maryland, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
View Trial Details
Completed

A Study of JNJ-75348780 in Participants With Non-Hodgkin Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)

NCT04540796

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +15 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Icahn School of Medicine at Mount Sinai New York, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
  • Austin Hospital Heidelberg, Australia
View all 32 locations
View Trial Details
Completed

Study to Investigate the Safety and Tolerability of Odronextamab in Patients With CD20+ B-Cell Malignancies

NCT02290951

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +20 more
Locations
  • University of California, Irvine Orange, California, United States
  • Stanford University Stanford, California, United States
  • H. Lee Moffitt Cancer Center Tampa, Florida, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
View all 22 locations
View Trial Details

Related conditions